Evidence map›Paper›PMID 29201167›Full record

ArticleExperimental and therapeutic medicine2017

CHAF1A, the largest subunit of the chromatin assembly factor 1 complex, regulates the growth of H1299 human non-small cell lung cancer cells by inducing G0/G1 cell cycle arrest.

Tanzhen Liu, Jingjing Wei, Chao Jiang, Chen Wang, Xiaoqin Zhang, Yan Du, Jianqiang Li, Hui Zhao

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Marsdenia Tenacissima Extract Inhibits Proliferation and Promotes Apoptosis in Human Ovarian Cancer Cells.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tanzhen LiuDepartment of Respiratory Medicine, Second Affiliated Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Jingjing WeiDepartment of Respiratory Medicine, Second Affiliated Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Chao JiangDepartment of Respiratory Medicine, Second Affiliated Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Chen WangDepartment of Pathology, Second Affiliated Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Xiaoqin ZhangDepartment of Pathology, Second Affiliated Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Yan DuDepartment of Respiratory Medicine, Second Affiliated Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Jianqiang LiDepartment of Respiratory Medicine, Second Affiliated Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Hui ZhaoDepartment of Respiratory Medicine, Second Affiliated Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Second Hospital of Shanxi Medical University · CNShanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromatin assembly factor 1 subunit A (CHAF1A) is the largest subunit of the chromatin assembly factor 1 (CAF-1) complex that is implicated in the assembly of nucleosomes on newly synthesized DNA. The aim of the present study was to determine its expression and biological function in non-small cell lung cancer (NSCLC). The current study examined the levels of CHAF1A expression in 22 samples of NSCLC and corresponding normal lung tissues. Subsequently, endogenous CHAF1A expression in H1299 NSCLC cells was knocked down via lentiviral delivery of CHAF1A-targeting short hairpin RNA (shRNA), and cell proliferation, colony formation and cell cycle distribution were measured. The results demonstrated that levels of CHAF1A mRNA level were ~3-fold greater in NSCLC samples compared with adjacent normal tissues (P<0.05). shRNA-mediated silencing of CHAF1A significantly inhibited the proliferation and colony formation of H1299 cells, compared wirh the delivery of control shRNA (P<0.05). Furthermore, CHAF1A shRNA-transduced cells exhibited a significant increase in the percentage of S-phase cells and a significant decrease in the percentage of cells at the G0/G1 and G2/M phases, compared with control cells (P<0.05). Additionally, CHAF1A knockdown significantly decreased the expression of cyclin D1, cyclin-dependent kinase 2 and S-phase kinase-associated protein 2, and increased the expression of p21 and p27. This indicates that CHAF1A is upregulated in NSCLC and that its silencing suppresses the proliferation and colony formation of NSCLC cells, potentially by inducing G0/G1 cell cycle arrest. CHAF1A may therefore represent a potential therapeutic target to treat NSCLC.

Indexed as

cell cycle arrestchromatin assembly factor 1 subunit Agrowthlung cancer

Identifiers

PMID29201167
PMCPMC5704333
OpenAlexW2759775403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.